Improved Detection of Fibrotic Nonalcoholic Fatty Liver Disease in Community-Based Referrals
Metabolic Syndrome and Related Disorders · 2023-11 · 21 (9) · 475-478
DOI: 10.1089/met.2023.0092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolic Syndrome and Related Disorders, online erschienen am 15.11.2023. Verfasst von Cindy Piao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease with increasing rates globally. Patients with type 2 diabetes mellitus have higher risk of developing NAFLD. Patients with a higher degree of liver fibrosis in NAFLD are at an increased risk for liver-related mortality, but get missed easily during the referral process. This project aims to improve early detection and linkage-to-care of fibrotic NAFLD patients.
Methods
We utilized a combination of automated electronic health record (EHR)-based fibrosis (FIB)-4 score and directed provider education. A health-system wide FIB-4 score calculator that providers can easily add to their workflow for NAFLD patient triaging. Data were analyzed at 6 and 12 months after implementation.
Results
Postimplementation, there was an increase in patients referred to hepatology with higher degree of liver fibrosis and decreased referral to hepatology with low risk of liver fibrosis, measured by FIB-4 score. At baseline, ∼55% of referred patient to hepatology had FIB-4 score 1.3 when compared to preinterventions, 62% versus 45%. This is most pronounced in patients with severe fibrotic disease with FIB-4 score >2.67, 30% versus 12%.
Conclusions
Automated FIB-4 score in EHR can improve appropriate linkage-to-care for at-risk fibrotic NAFLD, especially when coupled with targeted provider education. The durability of such improvement is essential to study along with the need to increase broad acceptance across health systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of California, Davis, California, USA.
- Division of Gastroenterology and Hepatology, University of California, Davis, California, USA.
- Department of Public Health Sciences, University of California, Davis, California, USA.
- Division of Endocrinology, Diabetes and Metabolism, University of California, Davis, California, USA.
- Clinical Informatics, University of California, Davis, California, USA.
ORCID-Profile: Souvik Sarkar
Zitieren
APA
Piao, C., Arteaga, E. J., Chen, S., Guo, A., Macdonald, S. T., & Sarkar, S. (2023). Improved Detection of Fibrotic Nonalcoholic Fatty Liver Disease in Community-Based Referrals. Metabolic Syndrome and Related Disorders, 21(9), 475-478. https://doi.org/10.1089/met.2023.0092
Vancouver
Piao C, Arteaga EJ, Chen S, Guo A, Macdonald ST, Sarkar S. Improved Detection of Fibrotic Nonalcoholic Fatty Liver Disease in Community-Based Referrals. Metabolic Syndrome and Related Disorders. 2023;21(9):475-478. doi:10.1089/met.2023.0092
BibTeX
@article{Piao2023,
author = {Piao, Cindy and Arteaga, Elvis J and Chen, Shuai and Guo, Aili and Macdonald, Scott T and Sarkar, Souvik},
title = {Improved Detection of Fibrotic Nonalcoholic Fatty Liver Disease in Community-Based Referrals},
journal = {Metabolic Syndrome and Related Disorders},
year = {2023},
volume = {21},
number = {9},
pages = {475--478},
doi = {10.1089/met.2023.0092}
}
EUVIMED